[HTML][HTML] Hippocampal NMDA receptors and anxiety: at the interface between cognition and emotion
C Barkus, SB McHugh, R Sprengel, PH Seeburg… - European journal of …, 2010 - Elsevier
David De Wied had a fundamental interest in the brain and behaviour, with a particular
interest in the interface between cognition and emotion, and how impairments at this …
interest in the interface between cognition and emotion, and how impairments at this …
Glutamate and anxiety
V Bergink, HJGM Van Megen… - European …, 2004 - Elsevier
Although glutamate is a simple molecule, its actions in the limbic system and areas
concerning anxiety are complex and widespread. These actions are mediated through …
concerning anxiety are complex and widespread. These actions are mediated through …
New perspectives in glutamate and anxiety
CR Bermudo-Soriano, MM Perez-Rodriguez… - Pharmacology …, 2012 - Elsevier
Anxiety and stress-related disorders, namely posttraumatic stress disorder (PTSD),
generalized anxiety disorder (GAD), obsessive–compulsive disorder (ODC), social and …
generalized anxiety disorder (GAD), obsessive–compulsive disorder (ODC), social and …
Association of oxidative stress to the genesis of anxiety: implications for possible therapeutic interventions
W Hassan, C Eduardo Barroso Silva… - Current …, 2014 - ingentaconnect.com
Oxidative stress caused by reactive species, including reactive oxygen species, reactive
nitrogen species, and unbound, adventitious metal ions (eg, iron [Fe] and copper [Cu]), is an …
nitrogen species, and unbound, adventitious metal ions (eg, iron [Fe] and copper [Cu]), is an …
Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal grey
FS Guimarães, AP Carobrez, JC De Aguiar… - …, 1991 - Springer
In order to localise the often reported anxiolytic action of N-methyl-D-aspartate (NMDA)
receptor antagonists, 2-amino-7-phosphonoheptanoic acid (AP7) was injected into the …
receptor antagonists, 2-amino-7-phosphonoheptanoic acid (AP7) was injected into the …
Effects of site-selective NMDA receptor antagonists in an elevated plus-maze model of anxiety in mice
JL Wiley, AF Cristello, RL Balster - European journal of pharmacology, 1995 - Elsevier
NMDA receptor antagonists have been shown to be anxiolytic in animal models of anxiety,
although they have not been tested extensively. These compounds bind to several specific …
although they have not been tested extensively. These compounds bind to several specific …
Acute effects of ketamine in the holeboard, the elevated‐plus maze, and the social interaction test in Wistar rats
JS Silvestre, R Nadal, M Pallares… - Depression and …, 1997 - Wiley Online Library
Although noncompetitive NMDA receptor antagonists have shown an anxiolyticlike profile in
several studies, such effects have not been observed consistently. Previous studies with …
several studies, such effects have not been observed consistently. Previous studies with …
Metabotropic and ionotropic glutamate receptors as neurobiological targets in anxiety and stress-related disorders: focus on pharmacology and preclinical …
BH Harvey, M Shahid - Pharmacology Biochemistry and Behavior, 2012 - Elsevier
Anxiety disorders are amongst the most common and disabling of psychiatric illnesses and
have severe health and socio-economic implications. Despite the availability of a number of …
have severe health and socio-economic implications. Despite the availability of a number of …
Anxiolytic-like effects of 7-nitroindazole in the rat plus-maze test
It is considered that nitric oxide (NO) is one of the most interesting research subjects.
Because the actual role of NO in the mechanism of anxiety is still unclear, in this study, the …
Because the actual role of NO in the mechanism of anxiety is still unclear, in this study, the …
N-methyl-D-aspartate antagonists and working memory performance: comparison with the effects of scopolamine, propranolol, diazepam, and …
MJ Pontecorvo, DB Clissold, MF White… - Behavioral …, 1991 - psycnet.apa.org
The effects of the competitive N-methyl-D-aspartate (NMDA) antagonists CPP (5 & 10 mg/kg)
and NPC 12626 (25 & 40 mg/kg) and the noncompetitive NMDA antagonists phencyclidine …
and NPC 12626 (25 & 40 mg/kg) and the noncompetitive NMDA antagonists phencyclidine …